Nanoscope Therapeutics Reports P-IIb Trial (RESTORE) Results of MCO-010 for the Treatment of Retinitis Pigmentosa
Shots: The P-IIb trial evaluating MCO-010 (IVT) vs PBO in 27 patients showed visio...
Shots: The P-IIb trial evaluating MCO-010 (IVT) vs PBO in 27 patients showed visio...
Shots: The P-IV study (EARNEST) evaluating vedolizumab vs PBO in patients who had...
Shots: The P-I study evaluates Rybrevant as a monotx. and in combination with Laze...
Shots: The first patient has been dosed in a P-I open-label, first-in-human dose e...
Shots: The first patient has been dosed in the P-I trial that consists of 2 parts...
Shots: Results showed a reduction in body weight of up to a mean of 4.2% from base...
Incisive News in 3 Shots.